CCC Diagnostics, Inc

CCC Diagnostics, Inc. (“CCC Diagnostics”) is a molecular diagnostic company, whose mission is to help physicians design the most effective, personalized chemotherapy regimens for cancer patients. CCC Diagnostics has developed and is currently offering the DirectHit® Test Panel for Breast Cancer which predicts, with a high degree of accuracy, the breast cancer tumor’s resistance and sensitivity to four commonly prescribed classes of drugs. CCC Diagnostics owns and operates a CLIA compliant testing laboratory to perform its diagnostic tests.